Effects of single and combined metformin and l-citrulline supplementation on l-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications-Reference-Cited by-同舟云学术

Effects of single and combined metformin and l-citrulline supplementation on l-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications

Published:2018-07-12 Issue:10 Volume:50 Page:1391-1406
ISSN:0939-4451
Container-title:Amino Acids
language:en
Short-container-title:Amino Acids

Author:

Hanff Erik,Hafner Patricia,Bollenbach Alexander,Bonati Ulrike,Kayacelebi Arslan Arinc,Fischer Dirk,Tsikas Dimitrios

Funder

Tomi-Hopf-Stiftung

Lorenzo-Piaggio

Neuromuscular Research Association Basel

University of Basel Children’s Hospital

Department of Neurology, University Hospital Basel

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Clinical Biochemistry,Biochemistry

Link

http://link.springer.com/article/10.1007/s00726-018-2614-7/fulltext.html

Reference74 articles.

1. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23:1455–1459

2. Alesutan I, Feger M, Tuffaha R, Castor T, Musculus K, Buehling SS, Heine CL, Kuro-O M, Pieske B, Schmidt K, Tomaschitz A, Maerz W, Pilz S, Meinitzer A, Voelkl J, Lang F (2016) Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine. Cardiovasc Res 110:408–418

3. Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS (2002) Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Metabolism 51:843–846

4. Banerjee B, Sharma U, Balasubramanian K, Kalaivani M, Kalra V, Jagannathan NR (2010) Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. Magn Reson Imaging 28:698–707

5. Barakat-Haddad C, Shin S, Candundo H, Lieshout PV, Martino R (2017) A systematic review of risk factors associated with muscular dystrophies. Neurotoxicology 61:55–62

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy;Cells;2024-03-26

2. GC–MS analysis of 4-hydroxyproline: elevated proline hydroxylation in metformin-associated lactic acidosis and metformin-treated Becker muscular dystrophy patients;Amino Acids;2024-03-10

3. GC–MS and GC–MS/MS measurement of malondialdehyde (MDA) in clinical studies: Pre-analytical and clinical considerations;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-11

4. An update on Becker muscular dystrophy;Current Opinion in Neurology;2023-08-21

5. Pan-Neurofascin autoimmune nodopathy – a life-threatening, but reversible neuropathy;Current Opinion in Neurology;2023-07-28